By Lisa Rapaport
(Reuters Health) - Teens and young adults with diabetes may do a
better job of checking their blood sugar when they get daily
financial incentives than when there’s no cash on the line, a recent
experiment suggests.
Researchers tested out the potential for money to motivate young
people to test blood sugar daily by offering $60 a month up front
and then subtracting $2 for each day a participant didn’t follow
through on required testing. For three months, researchers randomly
selected 90 teens and young adults to get these cash incentives or
no reward at all.
Overall, the youth with money at stake met their daily blood sugar
testing goals half of the time, while without rewards, participants
only met their testing goals 19 percent of the time.
“The young people felt motivated and empowered to find ways to check
their glucoses more with money on the line,” said lead study author
Dr. Charlene Wong of Duke University in Durham, North Carolina.
“They were especially motivated by the increasing losses if they
missed the goal multiple days in a row,” Wong said by email.
All of the study participants had what’s known as type 1 diabetes.
This chronic condition, typically diagnosed in children and young
adults, occurs when the pancreas produces little or no insulin, a
hormone needed to allow blood sugar, or glucose, to enter the body’s
cells.
People with type 1 diabetes typically have to test their own blood
sugar levels throughout the day and inject insulin to manage it.
Poorly controlled diabetes can lead to cardiovascular disease,
kidney complications and death.
While young children typically manage their blood sugar with a lot
of help and supervision from their parents, daily blood sugar
monitoring often gets worse in adolescence as children start to take
over responsibility for their own care, researchers note in JAMA
Pediatrics.
To see if cash could help improve the odds of teens doing these
daily tests, researchers turned to what’s known as behavioral
economics to see if the threat of losing prize money might be a more
powerful motivator than the promise of winning money.
Study participants were 16 years old on average, and most of them
were full-time students living at home.
[to top of second column] |
All of them were given daily blood sugar monitoring goals of testing
at least four times a day with at least one result within a safe or
normal range.
The teens who could get cash did better at testing during the three
months when the financial incentives were offered. But when
researchers followed participants for an extra three months without
any cash on the line, the differences between the groups
disappeared.
There also wasn’t a meaningful difference in blood sugar levels
based on whether or not the youth could receive cash rewards, either
at three months or at six months.
“The intervention was designed for the teenage brain, as it provided
short-term monetary rewards for health behaviors,” said Dr. Joyce
Lee, author of an accompanying editorial and a researcher at the
University of Michigan Medical School in Ann Arbor.
“However, the study did not necessarily translate to better
controlled blood sugar in the long-term,” Lee said by email.
“Checking blood sugars is important for diabetes care, but taking
insulin is also really important and the study did not incentivize
behavior related to insulin dosing.”
That doesn’t mean there is no place for behavioral economics in
trying to motivate teens to take charge of their health, Lee said.
The idea of loss aversion, or offering a prize that can go away, may
have potential to get youth to meet testing goals.
“This study shows that there are new opportunities to “nudge”
healthy behaviors teens with in type 1 diabetes using connected
diabetes devices and mobile technology,” Lee added. “But I would
caution parents that we need more studies to determine the long-term
efficacy of these behavioral economics interventions.”
SOURCE: http://bit.ly/2iBcZLD and http://bit.ly/2ySU9Wt JAMA
Pediatrics, online October 23, 2017.
[© 2017 Thomson Reuters. All rights
reserved.] Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |